The Veterinary Diagnostics Market has a relatively high growth rate compared to human in vitro diagnostic markets. The main reasons are the increase of animal agriculture and the increase of pet markets. The common screening method for such application is the Lateral Flow Assays (LFA) fast screening diagnosis, which provides extremely fast detection, but often has false negative results due to low sensitivity. Nucleic acid-based detection platforms provide more accurate results and therefore is the preferred methodology.

BiOptic’s R&D team has developed the core products of Qsep series instruments, which are fully-automated capillary gel electrophoresis (CGE) platforms for nucleic acid applications. BiOptic has also launched the newly developed mini PCR instrument Qamp mini and DirectGO PCR reagents that can simplify the nucleic acid extraction step. Usually, nucleic acid needs to be extracted before amplification. However, by utilizing BiOptic’s direct-PCR + CGE platform the detection time can be greatly reduced. The overall time to complete a full test (sample to result) is one hour.